Anti-Tumor Effects of Low Dose Zoledronate on Lung Cancer-Induced Spine Metastasis

Anti-Tumor Effects of Low Dose Zoledronate on Lung Cancer-Induced Spine Metastasis

Zoledronate (Zol) is an anti-resorptive/tumoral agent used for the treatment of many cancers including spinal bone metastasis. High systemic administration of a single dose is now the standard clinical care, yet it has been associated with several side effects. Here, we aimed to evaluate the effects...

Full description

Bibliographic Details
Main Authors: Elie Akoury, Ana Sofia Ramirez Garcia Luna, Pouyan Ahangar, Xiaoya Gao, Pylyp Zolotarov, Michael H. Weber, Derek H. Rosenzweig
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Journal of Clinical Medicine
Subjects:
spinal bone metastasis
lung cancer
zoledronate
low dose treatment
Online Access:https://www.mdpi.com/2077-0383/8/8/1212

Internet

https://www.mdpi.com/2077-0383/8/8/1212

Similar Items